Q2 2018 Holdings
Filed 2018-08-14 | 15 holdings | $22.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $14.9M | 649,763 | 66.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.0M | 150,000 | 18.0% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $3.4M | 118,873 | 15.1% |
| Merus N V | COM | N5749R100 | $28.5K | 1,250,914 | 0.1% |
| Loxo Oncology Inc | COM | 548862101 | $22.0K | 126,812 | 0.1% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $14.1K | 2,007,899 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $10.0K | 1,975,098 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $6.6K | 580,229 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $6.1K | 416,691 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $6.1K | 66,050 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $3.0K | 306,794 | 0.0% |
| Spdr Series Trust(XBI)Put | S&P Biotech | 78464A870 | $1.4K | 600,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $1.0K | 64,881 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $303 | 10,000 | 0.0% |